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Abstract 
Background: Human T-lymphotropic Virus Type I (HTLV-1) is a retrovirus that persistently infects 5–10 million indi-
viduals worldwide and causes disabling or fatal inflammatory and malignant diseases. The majority of the HTLV-1 
proviral load is found in CD4+ T cells, and the phenotype of adult T cell leukemia (ATL) is typically CD4+. HTLV-1 also 
infects CD8+ cells in vivo, but the relative abundance and clonal composition of the two infected subpopulations 
have not been studied. We used a high-throughput DNA sequencing protocol to map and quantify HTLV-1 proviral 
integration sites in separated populations of CD4+ cells, CD8+ cells and unsorted peripheral blood mononuclear cells 
from 12 HTLV-1-infected individuals.
Results: We show that the infected CD8+ cells constitute a median of 5 % of the HTLV-1 proviral load. However, HTLV-
1-infected CD8+ clones undergo much greater oligoclonal proliferation than the infected CD4+ clones in infected 
individuals, regardless of disease manifestation. The CD8+ clones are over-represented among the most abundant 
clones in the blood and are redetected even after several years.
Conclusions: We conclude that although they make up only 5 % of the proviral load, the HTLV-1-infected CD8+ 
T-cells make a major impact on the clonal composition of HTLV-1-infected cells in the blood. The greater degree of oli-
goclonal expansion observed in the infected CD8+ T cells, contrasts with the CD4+ phenotype of ATL; cases of CD8+ 
adult T-cell leukaemia/lymphoma are rare. This work is consistent with growing evidence that oligoclonal expansion 
of HTLV-1-infected cells is not sufficient for malignant transformation.
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Background
The retrovirus Human T-Lymphotropic Virus Type I 
(HTLV-1) causes a life-long infection in an estimated 
5–10 million individuals world-wide, resulting in disa-
bling or fatal inflammatory and malignant diseases in 
~10 % of infected people [1]. It is not completely under-
stood what determines an individual’s risk of these 
HTLV-1-associated diseases; however, a high proviral 
load (PVL; the number of proviral copies per 100 cells) 
in peripheral blood mononuclear cells (PBMCs) is cor-
related with the risk of both the central nervous system 
inflammatory disease known as HTLV-1-associated 
myelopathy/tropical spastic paraparesis (HAM/TSP) and 
the malignant disease adult T-cell leukemia/lymphoma 
(ATL) [2, 3].
HTLV-1 can infect most nucleated mammalian cells 
in  vitro, including both CD4+ and CD8+ T cells, but 
in vivo the virus is predominantly found in CD4+ T cells 
[4, 5]. The reasons for this preferential carriage in CD4+ 
T cells in  vivo are not clear; mechanisms related to the 
cell-type distribution of cellular receptors for HTLV-1 
[6] and to long-term selection in vivo [7] have been sug-
gested. ATL is typically a malignancy of CD4+ cells [8, 9]. 
The standard model of HTLV-1-driven cell transforma-
tion focuses on life-long clonal expansion of HTLV-1-in-
fected CD4+ cells as a precursor to malignancy [10].
HTLV-1-infected CD8+ cells may have great impor-
tance. Tax-specific CD8+ cells are themselves more 
likely than CD8+ cells specific to another virus to be 
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infected with HTLV-1 [11]. Virus-specific CD8+ cells 
can both exert a protective antiviral effect and contrib-
ute to the pathogenesis of viral diseases such as HAM/
TSP. It is unknown which of the effects attributed to the 
Tax-specific CD8+ cells result from their infection status, 
and there are conflicting reports in the literature on their 
functionality [12–14].
High-throughput analysis of proviral integration sites 
[15] has given new insights into the integration site pref-
erences and frequency distribution of HTLV-1- infected 
clones in asymptomatic carriers (AC) of the virus and in 
patients with the different disease manifestations [15–
17]; the relationship between integration site, HTLV-1 
clonality, proviral expression and the immune response 
[18, 19]; and the integration site and clonality in related 
retroviruses [20–22]. Since there is typically a single 
integrated HTLV-1 provirus per cell [23] the number of 
HTLV-1-infected clones can be quantified by the abun-
dance of observed integration sites.
Previous analyses of HTLV-1 integration were carried 
out on populations of unsorted PBMCs, and so did not 
distinguish between the different cell populations, in 
particular CD8+ and CD4+ T cells. The objective of the 
current study was to analyse the clonality of HTLV-1-in-
fected CD4+ and CD8+ cells in both unsorted PBMCs 
and purified CD4+ and CD8+ populations, and quantify 
the contribution to the HTLV-1 proviral load made by 
each respective population.
Results
Five percent of the proviral load of HTLV‑1 is carried 
by CD8+ cells
In order to separate CD4+ and CD8+ cells, purified 
PBMCs from 12 HTLV-1-infected subjects (6 ACs and 
6 patients with HAM/TSP; Table  1) were magnetically 
sorted on the basis of cell surface expression of CD4 
or CD8. The purity of sorted samples was measured by 
flow cytometry, and DNA extracted from the sorted and 
unsorted populations was used to assay the proviral load 
by quantitative PCR (qPCR) and to analyse clonality by 
high-throughput sequencing. We used the clonality anal-
ysis to study each sorted cell population separately, and 
to determine whether clones identified in the unsorted 
(PBMC) population were CD4+ or CD8+. We attributed 
72.8 % of all clones to either CD4+ or CD8+ cells (Addi-
tional file 1: Figure S1). Clones which were not attributed 
had a significantly lower absolute abundance and were 
therefore less likely to be detected in both the sorted 
cells and the PBMCs. The median frequency of con-
taminating CD4+ cells in the CD8+ fraction was 0.47 % 
(range 0.07–2.07  %) and the median frequency of con-
taminating CD8+ cells in the CD4+ fraction was 0.94 % 
(0.43–5.44 %).
The proviral load in the sorted and unsorted popula-
tions (Additional file  2: Table S1) was measured using 
qPCR. As expected in this cohort, unsorted cells had a 
high proviral load (median 5 copies, range 3.7 to 11.33 
Table 1 Subject samples used in this work
PBMC samples from 12 HTLV-1-infected individuals were examined in this work
Details of the CD4+, CD8+ cell populations are shown here
a HEZ Hepatitis of unknown origin (negative for HCV, HBV)
b HGL considered to be asymptomatic carrier at time of blood sample, but was diagnosed with HAM/TSP about a year later
c TDL absolute cell counts from an earlier timepoint (1 month earlier)
Subject Known comorbidities Absolute cell 
counts (cells/
µl)
Populations within T cells  
(%)
Populations in PBMC (%)
Code Clinical diagnosis CD4+ CD8+ CD4+/CD3+ CD8+/CD3+ CD3+CD4+ in total CD3+CD8+ in total
HBX AC None NA NA 66.3 29.5 30.8 13.7
HBZ AC None 948 284 74.1 21.1 41.2 11.7
HCP AC None 732 335 60.5 29.4 22.1 10.7
HEZ AC Hepatitisa 631 214 60.8 29.1 27.9 13.3
HGL ACb None 835 378 67.5 28.6 28.3 12
HHD AC None 1316 419 71.5 24.4 33.4 11.4
TAN HAM/TSP None 588 260 60.8 32.5 24.8 13.3
TAZ HAM/TSP None 1560 1058 46.4 42.5 29.3 26.8
TBW HAM/TSP None 300 1254 16.4 81.1 12.2 60.3
TDB HAM/TSP None 838 406 56.2 33.3 22.6 13.4
TDL HAM/TSP Shingles 1526c 707 60.6 34.8 32 18.3
TDT HAM/TSP None 752 392 59.2 32.5 29.7 16.3
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copies per 100 PBMCs). In the samples sorted for CD4+ 
or CD8+ cells, the median proviral load was 12.3 cop-
ies (6.0–30.2) and 2.0 (1.1–6.2) copies per 100 cells, 
respectively.
The proportion of the load carried by the CD8+ cells 
was calculated from the proviral load measured and the 
proportion of CD8+ cells in each population. The median 
proportion of the proviral load present in CD8+ cells was 
5.02  % (range 2.29–35.32  %, Fig.  1a; Additional file  2: 
Table S1). This estimate was confirmed using the high-
throughput sequence data, by using the proportion of all 
proviruses in the unsorted samples attributed to CD8+ 
clones. There was a strong linear correlation between 
the estimates from the two independent approaches 
(Additional file  3: Figure S2, Pearson linear regression, 
p < 0.0001, r = 0.969). An exceptionally high proportion 
of the load was carried in CD8+ cells in one case of HAM/
TSP (subject code TBW). This HIV-seronegative subject 
has a chronic idiopathic CD4+ lymphopenia leading to an 
extremely low CD4+/CD8+ ratio in his circulating T cells 
(Table 1). In this case, approximately 35 % of the provi-
ral load in the blood was carried in CD8+ T-cells. Due to 
the unique nature of the infection in this subject statisti-
cal analysis was carried out both including and excluding 
this case which did not alter our conclusions (Additional 
file 2: Table S3).
The contribution of CD8+ cells to the load was sig-
nificantly correlated with the proviral load in unsorted 
cells and with the proviral load in CD8+ cells (p = 0.02 
and p  =  0.01 respectively, Spearman’s rank correlation, 
Fig.  1a). There was no correlation between the proviral 
load in CD4+ cells and the contribution of CD8+ cells to 
the load.
HTLV‑1‑infected CD8+ cells are highly oligoclonal
We wished to compare the degree of oligoclonality 
between the infected CD8+ cells and the infected CD4+ 
cells in each subject. The proviral load in PBMCs was 
strongly correlated with both the proviral load in CD8+ 
cells (p  <  0.0001, Spearman’s rank correlation) and the 
proviral load in CD4+ cells (p = 0.004, Spearman’s rank 
correlation) (Fig. 1b).
We examined the distribution of the proviral load 
among the clones in each respective cell population. 
The CD8+ cell population contained fewer infected cells 
(Additional file  4: Figure S3A) and fewer clones (Addi-
tional file 4: Figure S3B) than the CD4+ population. The 
observed difference in the clone frequency distribution 
between the CD4+ samples and the CD8+ samples is 
illustrated in Fig.  2a (see also Additional file  5: Figure 
S4).
The oligoclonality index [15] is a measure of non-uni-
formity in the clone frequency distribution. The median 
oligoclonality index of the CD8+ samples was 0.60 (range 
0.53–0.83), significantly higher than that of the CD4+ 
samples (median 0.53, range 0.43–0.66) (p  =  0.0005, 
Wilcoxon signed rank test, Fig.  2b). That is, there was 
a less uniform clone frequency distribution—a greater 
degree of oligoclonality—in the CD8+ clones than in 
CD4+ clones. Whereas the infected CD4+ cell popula-
tion often consisted of one or few highly abundant clones 
and a large number of clones each of which was observed 
only once, the CD8+ population contained a significantly 
smaller total number of clones (p < 0.0001, Mann–Whit-
ney); and a much smaller proportion of the load in CD8+ 
cells was made up by singletons (clones observed only 
once) than in the CD4+ population (Fig. 2c).
We found, as observed before [15], no correlation 
between oligoclonality index and proviral load either in 
the unsorted PBMCs or in the CD4+ cells. In the CD8+ 
cells, however, there was a significant positive correlation 
(p = 0.017, Spearman’s rank correlation) between the oli-
goclonality and proviral load in CD8+ cells (Fig. 2d).
Fig. 1 Five percent of HTLV-1 proviral load is carried in CD8+ cells. 
HTLV-1-infected CD4+ and CD8+ cells were separated by magnetic 
bead sorting and analysed for their HTLV-1 proviral load and integra-
tion site frequency. a The number of proviral copies per 100 CD8+ 
cells and the percentage of contribution of CD8+ cells to the proviral 
load was quantified in 12 HTLV-1 carriers. The median percentage of 
the load carried by CD8+ cells was 5 %. A significant positive correla-
tion was found between the proportion of the total HTLV-1 proviral 
load in PBMCs that was carried by CD8+ cells and the proviral load 
in these cells (p = 0.01, Spearman’s rank correlation). Regression line 
based on linear regression excluding the CD4+ lymphopenic outlier 
(TBW); see text for details. b The proviral load (PVL, copies per 100 
cells) in unsorted PBMCs was strongly correlated with the proviral 
load in both CD8+ cells and CD4+ cells (p < 0.0001 and p = 0.004, 
respectively, Spearman’s rank correlation)
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The total number of clones observed in the CD4+ sam-
ples was significantly higher than in sorted CD8+ sam-
ples. However, it was also higher than the number in the 
unsorted PBMC samples. We hypothesize that this is due 
to enrichment of infected cells from small clones by cell 
sorting. We used the recently developed DivE method to 
estimate the total number of clones (clonal diversity) [24] 
in the blood. The estimated total number of CD8+ clones 
in the circulation was approximately tenfold less than 
that of CD4+ clones (Fig. 2e).
HTLV‑1‑infected CD8+ clones are over‑represented 
among the most abundant clones in non‑malignant 
HTLV‑1 infection
To quantify the relative contributions of CD4+ cells 
and CD8+ cells to the clone frequency distribution in 
unsorted PBMCs, we compared the clones identified in 
the CD4+ and CD8+ populations to the clones found in 
the unsorted PBMCs. The CD4+ or CD8+ phenotype of 
the 50 most abundant clones from each of the 12 subjects 
is shown in Fig. 3a. The phenotype of only one of the 600 
clones was not initially identified in this way; we identi-
fied it to be a CD8+ clone by sequence similarity. Unex-
pectedly, in 5 out of the 12 infected subjects (including 4 
of 6 HAM/TSP patients) the most abundant single clone 
was CD8+. In 8 of the 12 subjects (including all HAM/
TSP patients) a CD8+ clone was present among the 3 
most abundant clones. An extreme case was subject 
TBW (known to have a distorted CD4+/CD8+ ratio; see 
Table 1), in whom the proviral load was dominated by a 
large number of CD8+ clones, including the largest clone 
which represented over 15 % of the load.
To test whether CD8+ clones were more likely to be 
present among the most abundant clones than expected 
Fig. 2 HTLV-1 clone frequency distribution in sorted CD4+ and CD8+ cells. a Representative example of the difference in clonal distribution 
between CD4+ (left), CD8+ (middle) and unsorted (right) cells. Each slice of the pie chart represents a single observed clone, and the width of the 
slice is proportional to its relative abundance in the respective subject. The most abundant CD8+ clone constituted over 10 % of the load in CD8+ 
cells in this subject. OCI oligoclonality index [15]. b The HTLV-1 oligoclonality index was significantly higher in CD8+ cell samples than in CD4+ cell 
samples (p = 0.0005, paired Wilcoxon signed rank test). c The proportion of the load present in singletons (clones detected only once per sample) 
was significantly higher in CD4+ cells than in CD8+ cells (p = 0.002, Mann–Whitney test). d The oligoclonality index in CD8+ cells was significantly 
correlated with the proviral load in CD8+ cells (p = 0.017, Spearman’s rank correlation). No such correlation was observed in CD4+ cells or in 
unsorted PBMCs. e The observed total clone number (left panel) and estimated total number of clones in the blood (right panel) for sorted CD4+, 
CD8+ cells and unsorted PBMCs
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by chance, we compared the proportion of clones with 
an absolute abundance of more than 1 copy per 10,000 
PBMCs between CD4+ and CD8+ clones (Fig. 3b). This 
proportion was significantly greater in CD8+ clones 
(~10 %) than in the CD4+ clones (~5 %; p < 0.0001, Fish-
er’s exact test). Ranking all clones in descending order of 
abundance (Fig. 3c), CD8+ clones were found more often 
among the 10 most abundant clones (clone 1–10) than in 
the next 10 (clones 11–20; p = 0.012, Fisher’s exact test).
The abundant CD4+ and CD8+ HTLV‑1‑infected T‑cell 
clones are long‑lived in vivo
In a previous study of the long-term survival of HTLV-1 
clones in PBMCs we observed that a large proportion of 
the proviral load is made up of clones which can be rede-
tected in the blood over many years of infection [15]. 
Here, we wished to test whether the highly abundant 
CD8+ clones are maintained over time in the blood or 
whether they are succeeded (replaced) by other clones. 
Fig. 3 CD8+ clones are over-represented among the most abundant HTLV-1-infected clones in the blood. The clones detected by integration site 
analysis of PBMC samples from 12 HTLV-1-infected subjects were identified as either CD4+ or CD8+ if they were re-detected in the sorted samples. 
a The 50 most abundant clones are shown for each patient. For each clone, the number of proviruses detected is shown). The CD8+ clones (pink) 
included the most abundant single clone in 5/12 patients, and at least one of the three most abundant clones of 8/12 patients (including all HAM/
TSP patients). b CD8+ clones are significantly more likely to be of high abundance, i.e. clones with greater than 1 cell per 10000 PBMCs (p < 0.0001, 
Fisher’s exact test). c Clones were ranked in descending order of abundance. CD8+ clones were significantly more likely to be present among the 
top 10 clones than among the next 10 (clones 11–20) (p = 0.012, Fisher’s exact test)
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We analysed the integration sites in PBMC samples 
taken from each subject at a second timepoint, taken at a 
median interval of 3.4 years before or after the first sam-
ple analysed (range: 1.9–4.3 years). Sixty-four percent of 
CD4+ clones were redetected in samples taken at both 
timepoints, compared with 74 % of CD8+ clones. Because 
the abundance of a given clone determines its chance of 
redetection (Additional file 6: Figure S5A), we compared 
the proportion of redetected clones in bins of absolute 
clone abundance. As expected, the most abundant clones 
were consistently redetected at the second timepoint for 
both CD4+ and CD8+ clones; in the less abundant clones, 
CD8+ clones were redetected at least as frequently as 
CD4+ clones (Fig. 4, Additional file 6: Figure S5B).
HTLV‑1 infection alters the frequency of CD8+ cells but not 
CD4+ cells in peripheral blood
The proportion of the proviral load carried by CD8+ 
cells is determined by the load in the CD8+ cells and by 
the total frequency of CD8+ cells in the circulation. We 
found that the proviral load in CD8+ cells was positively 
correlated with the percentage of CD8+ T cells in PBMCs 
(Fig.  5, left panel) (p  =  0.02, Spearman rank correla-
tion). There was a positive trend of marginal significance 
between the proviral load in CD4+ cells and the percent-
age of CD8+ T cells in PBMCs (p  =  0.06, Fig.  5, right 
panel). A similar positive trend of marginal significance 
was observed between the proviral load in CD8+ and 
CD4+ cells and the percentage of CD8+ T cells within 
the T-cell population (p  =  0.06 and 0.07, respectively; 
Additional file  7: Figure S6A). There was no correlation 
between the proviral load in CD8+ or CD4+ cells and 
the percentage of CD4+ cells within PBMCs (Additional 
file  7: Figure S6B), suggesting that there is virus-driven 
selective expansion of CD8+ cells.
Discussion
HTLV-1 primarily infects CD4+ T-cells in  vivo, and the 
great majority of ATL cases are CD4+ [25]. The smaller, 
HTLV-1-infected CD8+ cell population has not been 
intensely studied. Small numbers of other cell types such 
as monocytes [26] may be infected. However, our data 
show that other cell types were unlikely to be present in 
the clonally expanded populations of HTLV-1-infected 
cells, because almost all (99.7 %) of the most highly abun-
dant clones were identified as CD4+ or CD8+ cells. Small 
numbers of CD4+ monocytes might have been included 
in the sorted CD4+ fraction, but this number is likely 
to be very small because monocytes are not efficiently 
selected by magnetic bead sorting owing to their lower 
expression of CD4+ [27].
Our results show that HTLV-1-infected CD8+ cell 
clones make an unexpectedly large impact on the clone 
frequency distribution observed in the blood. While 
the CD8+ clones represent only a minority (median 
5  %) of the proviral load, they are often highly repre-
sented among the most abundant clones in the blood, 
Fig. 4 Expanded CD8 and CD4 clones are long-lived. HTLV-1 infected 
clones from 12 subjects were compared at two independent time-
points (the one studied above, and a second one at a median interval 
of 3.4 years). Clones here were grouped into bins of increasing 
log(absolute abundance). Only clones that were identified as CD4+ or 
CD8+ are shown here. For each abundance bin, the CD4+ and CD8+ 
clone data from each patient were compared to test the proportion 
of clones that were redetected at the second timepoint. Abundant 
clones (either CD4+ or CD8+) were likely to be redetected at a second 
timepoint. Within each abundance bin, CD8+ clones were redetected 
at least as frequently as CD4+ clones
Fig. 5 Correlation between proviral load in CD8+ cells and the 
proportion of CD8+ cells in PBMCs. The proviral load (PVL, copies per 
100 cells) in CD8+ cells was strongly correlated with the proportion 
of CD8+ cells in PBMCs. The proportion of CD8+ cells in PBMCs is 
plotted against the proviral load in CD8+ cells (left panel; p = 0.02, 
Spearman’s rank correlation) and CD4+ cells (right panel; p = 0.06, 
Spearman’s rank correlation). The linear regression line was calculated 
excluding the CD4+ lymphopenic subject TBW (see text)
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and among the most long-lived clones (across all clone 
abundances).
Comparison of the clone frequency distribution of pro-
viruses between infected CD8+ and CD4+ cells revealed 
significant differences between the two populations. 
Whereas proviruses in infected CD4+ cells were present 
in a very large number of clones, each of which was often 
of low abundance, the clones observed in CD8+ T cells 
were often highly abundant. The oligoclonality index was 
significantly higher in CD8+ cell samples than in CD4+ 
cell samples and the proportion of the proviral load car-
ried by low-abundance clones (clones observed only 
once) was significantly higher among CD4+ cell samples.
Previous investigations of HTLV-1 clonality showed no 
correlation between the HTLV-1 proviral load and the 
oligoclonality index in non-malignant HTLV-1 infection, 
but the correlation was significant in malignant HTLV-1 
infection [15, 17, 20]. This observation was repeated here 
in the unsorted PBMCs; however, there was a significant 
positive correlation between the oligoclonality index 
in CD8+ cells and the proviral load in these cells. This 
observation suggests that the ratio of infectious spread 
(infection of new clones) to mitotic spread (proliferation 
of infected cells by increased mitotis or reduced apopto-
sis) differs between CD4+ and CD8+ cells during chronic 
HTLV-1 infection.
It is not known what mechanisms contribute to the 
difference in the degree of clonal expansion between 
the two cell types in HTLV-1 infection. We previously 
showed that the genomic integration site of the provirus 
plays a role in driving or silencing proviral gene expres-
sion, which in turn drives clonal expansion of CD4+ 
cells [15, 18]. However, infected CD8+ cells can express 
high levels of Tax and can then be killed by Tax-specific 
CD8+ cells [11, 28]. It is not known whether Tax-express-
ing CD4+ cells are killed as efficiently as Tax-expressing 
CD8+ cells. Proliferation of HTLV-1-infected CD8+ cells 
may be selectively enhanced by their response to spe-
cific antigen, such as those expressed by other persistent 
viruses or, perhaps most likely, antigens of HTLV-1 itself.
Oligoclonal expansion of Tax-specific CTLs has been 
reported [29], but it was not known whether these 
expanded clones are also infected by the virus. The 
notion that HTLV-1-infected, HTLV-1-specific CTLs 
grow to high abundance in the circulation is consistent 
with the previous observations that HTLV-1-specific 
CTLs are preferentially infected with HTLV-1 [11] and 
that the frequency of HTLV-1-specific CTLs is correlated 
with the proviral load [30, 31].
Sibon et  al. [32] cultured clones of HTLV-1-infected 
and uninfected CD4+ and CD8+ cells, and concluded 
that the more vigorous expansion observed in infected 
CD8+ cells in vitro was due to a reduction in apoptosis 
rather than increased proliferation. If this is also the case 
in vivo, it could explain how CD8+ clones proliferate and 
persist, with a low risk of generating the somatic muta-
tions that contribute to malignant transformation [33]. 
IL-15 has been shown to protect Tax-specific cells from 
apoptosis [34]. HTLV-1 Tax upregulates both IL-15 and 
its receptor [35, 36], and an increase in IL-15 mRNA has 
been observed in HAM/TSP patients [37]. Thus, HTLV-1 
may exploit a normal IL-15-dependent pathway for the 
maintenance of memory CD8+ cells [38] to maintain its 
own infected CD8+ cell population. Cytokine-dependent 
proliferation of infected CD8+ cells could also explain 
the observation made in this study that the proportion 
of CD8+ T cells in the PBMCs was positively correlated 
with the viral burden in the CD8+ cells: abundant IL-15 
secreted by infected cells could also drive proliferation of 
uninfected CD8+ T cells.
Previously [20] we reported the clone frequency dis-
tribution of HTLV-2, a virus closely related to HTLV-1; 
HTLV-2 is mainly found in CD8+ cells in infected indi-
viduals. Unlike HTLV-1, HTLV-2 does not cause leuke-
mia or lymphoma. The findings here and those observed 
in HTLV-2 infection share several similarities. As we 
observed in HTLV-1-infected CD8+ cells, HTLV-2 infec-
tion was characterized by a high oligoclonality index due 
to a small number of abundant clones in the absence of 
malignancy. The oligoclonality index in HTLV-2 was sig-
nificantly correlated with the proviral load, as observed 
here in HTLV-1-infected CD8+ (but not CD4+) cells. 
These observations suggest that physiological differences 
between CD8+ cells and CD4+ cells contribute to the 
observed differences in the clone frequency distribution 
between the two infected cell populations.
HTLV-1 infection is associated with a strong, constitu-
tively active anti-HTLV-1 cytotoxic T-lymphocyte (CTL) 
response. Virtually all individuals with non-malignant 
HTLV-1-infection possess CTLs specific to Tax peptides 
[39, 40]. The most immunogenic peptide encoded by the 
virus is Tax11-19, which is efficiently presented in the con-
text of HLA-A2 [41, 42]. Despite its high immunogenic-
ity, this peptide is highly conserved. HTLV-2 encodes a 
nearly identical immunodominant peptide [43]. It is pos-
sible that this highly immunogenic peptide provides a 
selective advantage to the virus by driving proliferation of 
infected, antigen-specific T cells.
We conclude that the combined mitotic and antigenic 
effects of Tax in maintaining proliferation of infected 
CD8+ T cells may outweigh the negative selection by 
Tax-specific CTL-mediated killing of the infected CD8+ 
T cells.
We recently showed that the HTLV-1 proviral load, 
the strongest predictor of the risk of both inflammatory 
disease (HAM/TSP) and malignant disease (ATL), does 
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not correlate with the degree of clonal expansion (the 
oligoclonality index), but rather with the total number 
of HTLV-1-infected clones. We also found, in an analy-
sis of the integration site preferences among ~200 ATL 
patients, that the malignant ATL clones resemble the 
low-abundance clones more closely than the intermedi-
ate-abundance clones that have undergone oligoclonal 
proliferation [16]. ATL can arise by the rapid emergence 
(within 18 months) of a previously rare clone, outgrow-
ing the pre-existing oligoclonally expanded clones [44]. 
Finally, HTLV-2 was found in highly abundant clones 
in  vivo, but this virus does not cause leukemia or lym-
phoma [20]. However, malignant diseases of CD8+ T 
cells are generally rarer than those of CD4+ T cells [45], 
suggesting that the cell type determines the risk of malig-
nancy. The viral mechanisms that cause clonal prolifera-
tion of HTLV-1-infected cells may be distinct from those 
that lead to malignant transformation.
Conclusions
The observation that HTLV-1 causes oligoclonal prolif-
eration of infected cells led to a widespread assumption 
that the oligoclonal proliferation predisposes to leukemo-
genesis. Here we show that contrary to that assumption, 
the cells that undergo the greatest clonal expansion in 
HTLV-1 infection are the HTLV-1-infected CD8+ cells. 
However, cases of CD8+ ATL are very rare. The results 
of the present study therefore add further to the conclu-
sion [44] that oligoclonal T-cell proliferation per se does 
not predispose to malignant disease in HTLV-1 infection. 
Further work is needed to determine the mechanisms 
involved with the selective expansion of certain CD8+ 




Blood samples and anonymized patient information were 
obtained through the Communicable Diseases Tissue 
Bank at Imperial College, approved by the UK National 
Research Ethics Service (NRES reference 09/H0606/106). 
Samples were donated by HTLV-1-infected subjects 
attending the National Centre for Human Retrovirology, 
St Mary’s Hospital, Imperial College Healthcare NHS 
Trust, London after giving written informed consent.
Cells and samples
PBMC samples from 12 HTLV-1-infected individu-
als were analysed. See Table  1 for details of samples 
used. The 12 subjects included 6 patients with HAM/
TSP and 6 asymptomatic carriers. ACs with a high PVL 
were selected; if the PVL is less than 0.1  % the number 
of proviruses sampled does not give adequate statistical 
power. One of the ACs (HGL) was diagnosed with HAM/
TSP approximately 1 year after the sample was taken.
PBMCs were isolated from blood using Histo-
paque-1077 (Sigma-Aldrich) and cryopreserved in fetal 
bovine serum (Gibco) containing 10  % dimethylsulfox-
ide (Sigma-Aldrich). DNA was extracted from sorted or 
unsorted cells using the DNeasy Blood and Tissue Kit 
(Qiagen) according to the manufacturer’s protocol, and 
eluted in Qiagen EB buffer.
Cell sorting
Uncultured, unfixed, cryopreserved PBMCs were sorted 
sequentially on the basis of CD4 and CD8 expression, 
using magnetic beads (Miltenyi). First, CD4+ cells were 
positively selected, and CD8+ cells were then selected 
from the CD4− fraction. The cells were passed twice over 
sorting columns at each stage, to maximize purity and 
recovery.
Purity testing and analysis of cell population frequency 
in unsorted samples was carried out using flow cytom-
etry, after fixation and staining for surface expression of 
CD3 (clone UCHT1, eBioscience), CD4 (clone RPA-T4, 
eBioscience) and CD8 (clone SFCI21Thy2D3, Beckman 
Coulter).
Clonality analysis
Genomic DNA was extracted from both the sorted and 
the unsorted cell populations, and from unsorted PBMCs 
at a second time point (median time difference 3.4 years) 
where available. Proviral integration sites were mapped 
and quantified as previously described [15]. Sequencing 
of amplified integration sites was done using the Illumina 
GAII, HiSeq or MiSeq platforms, using 50-base paired-
end reads and a 6-base barcode to allow multiplexing. 
Sequence data were aligned against a combined reference 
of the human genome (hg18) and the HTLV-1 genome 
sequence using an Eland implementation of CASAVA 
software (Illumina), then filtered and quantified for 
clone abundance using in-house software as previously 
described. See Additional file 2: Table S2 and Additional 
file 8 for details of the sequencing results.
Based on the assumption that HTLV-1 infects differen-
tiated, mature CD4 or CD8 single-positive cells, we attrib-
uted any integration site found in both CD4+ and CD8+ 
cells to the cell subpopulation (CD4+ or CD8+) in which it 
was identified with a higher frequency (greater number of 
proviruses). The frequency of these putative contaminat-
ing clones was significantly inversely correlated with the 
measured purity of the sample, and significantly positively 
correlated with the frequency of the contaminating popu-
lation and its share of the load (not shown).
Page 9 of 10Melamed et al. Retrovirology  (2015) 12:91 
Statistical analysis
Data analysis was carried out using R (http://www.R-
project.org/ [46]). The oligoclonality index was calculated 
using the package reldist [47]. Unless specified other-
wise, non-parametric statistical tests were used. A result 
was considered statistically significant when p  <  0.05 
(two-tailed).
The total number of clones present in the circulation 
was estimated using the DivE estimator [24]. DivE fits 
multiple mathematical models to individual-based rar-
efaction curves; such curves plot the expected number 
of clones against the number of infected cells sampled. 
Numerical criteria are then used to score models on their 
ability to accurately estimate additional data. The best-
performing models are extrapolated to estimate the total 
number of clones in the blood, based on the proviral load 
in the respective subject.
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